Clinical Trials Browser

Interventional × Thymoma × Thoracic × Clear all

NCT04375267 2026-04-14

LuPARP

Phase 1 Completed

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT03076554 2026-04-07

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Phase 2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Thymoma

NCT04417660 2026-04-07

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Active not recruiting

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT05104736 2026-04-07

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Recruiting

Thymic epithelial tumor, Peripheral Nervous System Diseases, Thymoma, Thymus Neoplasms

NCT03463460 2026-03-23

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Phase 2 Active not recruiting

Thymoma

NCT07479628 2026-03-18

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Phase 2 Not yet recruiting

Thymoma

NCT07132918 2026-03-11

HEARTS Trial for Thoracic Cancers

Phase 2 Recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Thymoma

NCT07463313 2026-03-11

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Phase 2/3 Not yet recruiting

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

NCT03968315 2026-03-09

An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

Phase NA Active not recruiting

Thymoma

NCT04710628 2026-02-19

PECATI

Phase 2 Completed

Thymoma

NCT06885697 2026-02-17

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Phase 1 Recruiting

GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thymoma, Thymus Neoplasms

NCT03295227 2026-01-30

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

Phase 1 Recruiting

Thymoma

NCT06248515 2026-01-27

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

Phase 2 Recruiting

Thymoma

NCT07324629 2026-01-09

Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma

Phase 2 Not yet recruiting

Thymoma

NCT01025089 2026-01-07

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Phase 2 Active not recruiting

Thymoma

NCT05544929 2026-01-06

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Phase 1 Active not recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Nasopharyngeal Carcinoma, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Nasopharyngeal Neoplasms, Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Skin Neoplasms, Thymoma, Thymus Neoplasms, Colorectal Neoplasms, Adenocarcinoma, Clear Cell, Triple Negative Breast Neoplasms

NCT05150210 2025-12-23

SP Thoracic IDE Study

Phase NA Active not recruiting

32 enrolled 8 charts

Myasthenia Gravis, Thymoma

NCT06838910 2025-12-01

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

Phase 2 Recruiting

Thymoma

NCT03694002 2025-10-30

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Phase 2 Completed

21 enrolled 17 charts

Thymoma

NCT06790706 2025-10-06

IMMUNORARE5

Phase 2 Recruiting

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT07181720 2025-10-02

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Phase 1 Recruiting

EndocrineGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thymoma, Thyroid Carcinoma, Anaplastic

NCT07179341 2025-09-17

Survival Nomogram for Patients With Thymic Carcinoma

Phase NA Completed

Thymoma

NCT06186726 2025-06-13

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Phase 2 Recruiting

Thymoma

NCT06545409 2025-03-25

SPRATS

Phase NA Recruiting

Thymoma

NCT06730308 2024-12-12

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

Phase 2 Recruiting

Thymoma

NCT06692062 2024-11-18

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

Phase NA Recruiting

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT03583086 2024-10-08

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Phase 1/2 Completed

88 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

NCT01306045 2024-10-01

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

Phase 2 Completed

647 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

NCT01621568 2024-09-24

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

Phase 2 Completed

56 enrolled 15 charts

Thymoma, Thymus Neoplasms

NCT04072393 2024-07-12

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Phase NA Terminated

BreastGastrointestinalLymphoidSarcomaThoracic

Breast Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Lung Neoplasms, Lymphoma, Non-Hodgkin, Sarcoma, Thymoma

NCT04321330 2024-06-11

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

Phase 2 Completed

Thymoma

NCT05682742 2024-06-03

Clinical Investigation of the da Vinci Surgical System

Phase NA Active not recruiting

GenitourinaryOtherThoracic

Genital Diseases, Female, Hernia, Inguinal, Hernia, Ventral, Mediastinal Neoplasms, Obesity, Morbid, Prostatic Diseases, Prostatic Neoplasms, Thymoma, Pelvic Organ Prolapse

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

NCT06402708 2024-05-10

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Phase 3 Recruiting

Thymoma

NCT04925947 2024-04-16

A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

Phase 2 Terminated

4 enrolled 10 charts

Thymoma

NCT04469725 2024-03-12

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Phase 2 Terminated

Thymoma

NCT06029621 2024-02-29

Robot-assisted vs VATS for Thymoma

Phase NA Recruiting

Thymoma

NCT02633553 2023-12-08

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Phase NA Recruiting

Thymoma

NCT02633514 2023-12-05

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Phase 3 Recruiting

Thymoma

NCT05455840 2023-10-31

A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease

Phase NA Unknown

Myasthenia Gravis, Thymoma

NCT04662645 2023-10-26

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers

Phase NA Completed

Lung Neoplasms, Thymoma

NCT05832827 2023-10-23

Artemis

Phase 2 Recruiting

Thymoma

NCT06086327 2023-10-17

Application of 68Ga-Pentixafor PET/CT for Thymoma

Phase EARLY_PHASE1 Unknown

Thymoma

NCT06019468 2023-09-06

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Phase 2 Unknown

Thymoma

NCT06010277 2023-08-24

FLEX

Phase 4 Unknown

Other solid neoplasmThoracic

Mesothelioma, Thymoma

NCT00010257 2023-06-29

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

Phase 2 Completed

46 enrolled 7 charts

Thymoma

NCT00003283 2023-06-15

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Phase 2 Completed

Thymoma

NCT05816694 2023-04-18

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

Phase 2 Not yet recruiting

Thymoma

NCT03134118 2023-02-21

NIVOTHYM

Phase 2 Unknown

Thymoma

NCT03193437 2023-02-16

SELECT

Phase 2 Terminated

8 enrolled 11 charts

Thymoma